Literature DB >> 8751388

MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14).

M Meddeb1, A Valent, G Danglot, V C Nguyen, A Duverger, F Fouquet, M J Terrier-Lacombe, O Oberlin, A Bernheim.   

Abstract

This report describes a case of rhabdomyosarcoma associated with a 2;13 translocation and multiple double minute chromosomes. The origin of the amplified DNA was identified using comparative genomic hybridization, which pinpointed a unique spot at 12q13-->q14. Band 12q13 has been shown to contain several genes that are occasionally amplified in other sarcomas. Fluorescene in situ hybridization to tumor metaphases with probes specific for this region indicated that the double minutes contained the MDM2 gene but not the CDK4 gene. MDM2 amplification was further quantified by Southern hybridization, which showed a mean value of 25 copies per haploid genome. This is the first example of MDM2 amplification in a rhabdomyosarcoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751388     DOI: 10.1159/000134368

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  9 in total

1.  Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

Authors:  A Pandita; M Zielenska; P Thorner; J Bayani; R Godbout; M Greenberg; J A Squire
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.

Authors:  Myriam Goldstein; Isaac Meller; Josephine Issakov; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 3.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 4.  Mechanisms of impaired differentiation in rhabdomyosarcoma.

Authors:  Charles Keller; Denis C Guttridge
Journal:  FEBS J       Date:  2013-07-31       Impact factor: 5.542

5.  Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer.

Authors:  Mohammad Hashemi; Shadi Amininia; Mahboubeh Ebrahimi; Nasser Simforoosh; Abbas Basiri; Seyed Amir Mohsen Ziaee; Behzad Narouie; Mehdi Sotoudeh; Mohammad Javad Mollakouchekian; Esmaeil Rezghi Maleki; Hamideh Hanafi-Bojd; Maryam Rezaei; Gholamreza Bahari; Mohsen Taheri; Saeid Ghavami
Journal:  Oncol Lett       Date:  2017-02-14       Impact factor: 2.967

6.  Small Circular DNAs in Human Pathology.

Authors:  Stephany Carolina Barreto; Madhuri Uppalapati; Amitabha Ray
Journal:  Malays J Med Sci       Date:  2014-05

7.  High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance.

Authors:  H A Cocker; S M Hobbs; N Tiffin; K Pritchard-Jones; C R Pinkerton; L R Kelland
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

8.  A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.

Authors:  Mohammad Hashemi; Mohsen Omrani; Ebrahim Eskandari-Nasab; Seyed-Shahaboddin Hasani; Mohammad Ali Mashhadi; Mohsen Taheri
Journal:  Iran Biomed J       Date:  2014

9.  Identification of functional DNA variants in the constitutive promoter region of MDM2.

Authors:  Marie-Eve Lalonde; Manon Ouimet; Mathieu Larivière; Ekaterini A Kritikou; Daniel Sinnett
Journal:  Hum Genomics       Date:  2012-09-01       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.